Get started
Author

Erina Koga‐Yamakawa

Observed names: E Koga-Yamakawa, E. Koga‐Yamakawa, Erina Koga-Yamakawa, Erina Koga-yamakawa
OpenAlex ID: A5066618643
A novel systemically administered toll‐like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
2014 · Amy L. Adlard, Simon J. Dovedi, et al. · International Journal of Cancer · 49
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
2021 · Alexander Spira, Aaron R. Hansen, et al. · Targeted Oncology · 32
PDF
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
2016 · Simon J. Dovedi, Amy L. Adlard, et al. · Oncotarget · 29
PDF
Intratracheal and oral administration of SM‐276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer
2012 · Erina Koga‐Yamakawa, Simon J. Dovedi, et al. · International Journal of Cancer · 28
PDF
TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice
2015 · Erina Koga-Yamakawa, Masashi Murata, et al. · Cancer Immunology Immunotherapy · 23
DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects
2023 · Yosuke Ota, Yasuhiro Nagai, et al. · Frontiers in Immunology · 17
PDF
Arabino-mycolates derived from cell-wall skeleton of Mycobacterium bovis BCG as a prominent structure for recognition by host immunity
2011 · Masanori Miyauchi, Masashi Murata, et al. · Drug Discoveries & Therapeutics · 16
PDF
Abstract 4726: Novel intravenous injectable TLR7 agonist, DSP-0509, synergistically enhanced antitumor immune responses in combination with anti-PD-1 antibody
2018 · Yosuke Ota, Takeshi Otsubo, et al. · Cancer Research · 10
Phagocytosis plays a dual role in activating dendritic cells; digestive production of active Toll-like receptor ligands and cooperation with Toll-like receptor signaling.
2010 · M Miyauchi, M Murata, et al. · PubMed · 5
Abstract 2567: Enhancement of antitumor activity of DSP-6434, a novel TLR7 agonist through reduction of TLR tolerance
2014 · Erina Koga-Yamakawa, Masashi Murata, et al. · Cancer Research · 1
Ps1344 Phase 1/2 Study of Dsp‐7888 in Patients With Higher‐risk (hr) Myelodysplastic Syndromes (mds) After Failure of Azacitidine (aza) Therapy
2019 · K. Usuki, Y. Ueda, et al. · HemaSphere
Works count: 12
Citation count: 210
H-index: 8
I10-index: 8
Year
Topic
Type